By Sarah Boseley, The Guardian Thursday, February 6, 2014 19:09 EST
Researchers say they have reversed equivalent of type 1 diabetes in mice using stem cell transplants
Scientists believe they may have moved a step closer to a cure for the type of diabetes that develops in childhood and usually leads to a lifetime of insulin injections.
Researchers in California report that they have reversed the equivalent of type 1 diabetes in mice through transplants of stem cells. Their experiments have replaced cells in the pancreas damaged by the disease that are unable to make insulin.
Without insulin, the body has difficulty absorbing sugars such as glucose from the blood. The disease usually first shows in childhood or early adulthood and used to be a killer, but glucose levels can now be monitored and regulated with insulin injections.
Scientists have long wanted to try to replace the damaged -cells that normally produce insulin. This has been one of the prime targets of stem cell experiments. But until now, it has proved difficult, partly because mature -cells do not readily regenerate.
Writing in the journal Cell Stem Cell, scientists at the Gladstone Institutes in San Francisco describe how they took a step back and collected skin cells, called fibroblasts, from laboratory mice. Then, by treating the fibroblasts with a unique cocktail of molecules and reprogramming factors, they transformed the cells into endoderm-like cells. Endoderm cells are a type of cell found in the early embryo, and which eventually mature into the bodys major organs including the pancreas. Using another chemical cocktail, we then transformed these endoderm-like cells into cells that mimicked early pancreas-like cells, which we called PPLCs, said the Gladstone postdoctoral scholar Ke Li, the papers lead author. Our initial goal was to see whether we could coax these PPLCs to mature into cells that, like -cells, respond to the correct chemical signals and most importantly secrete insulin. And our initial experiments, performed in a petri dish, revealed that they did.
The team then injected these cells into mice that had been genetically modified to have high glucose levels, mimicking the type 1 diabetes condition in humans.
Importantly, just one week post-transplant, the animals glucose levels started to decrease, gradually approaching normal levels, said Li. And when we removed the transplanted cells, we saw an immediate glucose spike, revealing a direct link between the transplantation of the PPLCs and reduced hyperglycemia [high glucose level].
Continued here:
Scientists move closer to stem cell cure for Type 1 ...
- Savage on Embryonic Stem Cells and Obama - March 13th, 2011 [March 13th, 2011]
- Is stem cell research ethical? - November 20th, 2012 [November 20th, 2012]
- Stem Cell Experiments | eHow - eHow | How to Videos, Articles ... - November 26th, 2013 [November 26th, 2013]
- Joshua Hare Wins Grant to Take Stem Cell Experiments to Space ... - November 27th, 2013 [November 27th, 2013]
- Stem cell experiments in genetic blood diseases Vector - March 14th, 2014 [March 14th, 2014]
- FDA Approves Embryonic Stem Cell Experiments on Humans - April 30th, 2014 [April 30th, 2014]
- Induced Pluripotent Stem Cell Experiments by Kazutoshi ... - June 3rd, 2015 [June 3rd, 2015]
- New Stem Cell Cancer Treatment on the Horizon? - July 6th, 2018 [October 17th, 2017]